{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-23-000058","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2023-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.704052+00:00","generated_at":"2026-06-10T01:53:11.333247+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Humana names Jim Rechtin as COO and CEO successor; Broussard to step down in H2 2024","bullets":["Jim Rechtin appointed President & COO effective Jan 8, 2024; will become CEO in latter half of 2024.","Bruce Broussard, CEO since 2013, to step down as CEO in H2 2024 and remain as strategic advisor into 2025.","Rechtin's base salary $1.1M as COO, rising to $1.25M as CEO; eligible for 150%/200% STI target levels.","Initial equity award: $3M RSUs and $3M stock options; 2024 annual equity grant valued at $6M.","Rechtin previously CEO of Envision Healthcare, President of OptumCare; brings value-based care experience."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-23-000058","json":"https://secwatch.observer/filing/0000049071-23-000058.json","markdown":"https://secwatch.observer/filing/0000049071-23-000058.md","text":"https://secwatch.observer/filing/0000049071-23-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000058/0000049071-23-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000058/hum-20231009.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T01:53:11.333247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1afa050a20","claim":"Bruce D. Broussard departed as Chief Executive Officer at HUMANA INC.","evidence_excerpt":"As part of a multi-year succession plan, the Company expects that Mr. Broussard will step down as Chief Executive Officer in the latter half of 2024 and that Mr. Rechtin would become President and Chief Executive Officer at that time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000058/0000049071-23-000058-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"step down"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c0e265a72c","claim":"James A. Rechtin was appointed as President and Chief Operating Officer at HUMANA INC.","evidence_excerpt":"On October 11, 2023, Humana Inc. (the “Company”) announced the election of James A. Rechtin (“Mr. Rechtin”), age 52, to serve as the Company’s President and Chief Operating Officer, effective as of the later of (x) January 8, 2024, or (y) commencement of his employment with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000058/0000049071-23-000058-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}